Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
6.25
-0.21 (-3.18%)
Apr 29, 2026, 1:39 PM EDT - Market open
Harvard Bioscience Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 8.61 | 4.11 | 4.28 | 4.51 | 7.82 | Upgrade
|
| Cash & Short-Term Investments | 8.61 | 4.11 | 4.28 | 4.51 | 7.82 | Upgrade
|
| Cash Growth | 109.69% | -4.09% | -4.99% | -42.36% | -5.96% | Upgrade
|
| Accounts Receivable | 16.04 | 14.87 | 16.1 | 16.71 | 21.83 | Upgrade
|
| Receivables | 16.04 | 14.87 | 16.1 | 16.71 | 21.83 | Upgrade
|
| Inventory | 20.81 | 23.25 | 24.72 | 26.44 | 27.59 | Upgrade
|
| Other Current Assets | 2.76 | 2.9 | 3.94 | 3.47 | 4.34 | Upgrade
|
| Total Current Assets | 48.23 | 45.12 | 49.04 | 51.12 | 61.58 | Upgrade
|
| Property, Plant & Equipment | 11.96 | 11.24 | 8.75 | 9.18 | 10.31 | Upgrade
|
| Long-Term Investments | - | - | 3.5 | - | - | Upgrade
|
| Goodwill | 9.56 | 56.32 | 57.07 | 56.26 | 57.69 | Upgrade
|
| Other Intangible Assets | 7.64 | 11.13 | 16.04 | 21.01 | 27.39 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 0.09 | 0.44 | 0.33 | 0.21 | Upgrade
|
| Other Long-Term Assets | 2.69 | 2.74 | 2.54 | 7.45 | 5.17 | Upgrade
|
| Total Assets | 80.07 | 126.64 | 137.37 | 145.36 | 162.34 | Upgrade
|
| Accounts Payable | 3.65 | 4.79 | 5.55 | 6.45 | 4.91 | Upgrade
|
| Accrued Expenses | 3.56 | 2.26 | 4.43 | 3.87 | 6.53 | Upgrade
|
| Current Portion of Long-Term Debt | - | 36.96 | 5.86 | 3.81 | 3.24 | Upgrade
|
| Current Portion of Leases | 1.53 | 1.16 | 1.42 | 2.14 | 2.14 | Upgrade
|
| Current Income Taxes Payable | - | - | - | - | 0.22 | Upgrade
|
| Current Unearned Revenue | 3.45 | 3.81 | 4.51 | 3.37 | 4.27 | Upgrade
|
| Other Current Liabilities | 9.78 | 5.99 | 4.78 | 3.62 | 4.01 | Upgrade
|
| Total Current Liabilities | 21.96 | 54.96 | 26.54 | 23.25 | 25.32 | Upgrade
|
| Long-Term Debt | 35.87 | 0.1 | 30.9 | 43.01 | 45.1 | Upgrade
|
| Long-Term Leases | 6.88 | 6.38 | 4.79 | 5.28 | 6.49 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.32 | 0.71 | 0.78 | 0.59 | 1.56 | Upgrade
|
| Other Long-Term Liabilities | 1.31 | 1.16 | 1.28 | 1.01 | 0.49 | Upgrade
|
| Total Liabilities | 66.34 | 63.3 | 64.29 | 73.14 | 78.94 | Upgrade
|
| Common Stock | 0.45 | 0.44 | 0.43 | 0.45 | 0.45 | Upgrade
|
| Additional Paid-In Capital | 239.67 | 236.58 | 232.44 | 229.01 | 225.65 | Upgrade
|
| Retained Earnings | -214.71 | -158.01 | -145.61 | -142.19 | -132.67 | Upgrade
|
| Comprehensive Income & Other | -11.67 | -15.67 | -14.19 | -15.05 | -10.03 | Upgrade
|
| Shareholders' Equity | 13.73 | 63.34 | 73.07 | 72.22 | 83.4 | Upgrade
|
| Total Liabilities & Equity | 80.07 | 126.64 | 137.37 | 145.36 | 162.34 | Upgrade
|
| Total Debt | 44.28 | 44.59 | 42.97 | 54.24 | 56.96 | Upgrade
|
| Net Cash (Debt) | -35.66 | -40.49 | -35.19 | -49.73 | -49.14 | Upgrade
|
| Net Cash Per Share | -8.03 | -9.30 | -8.30 | -12.01 | -12.18 | Upgrade
|
| Filing Date Shares Outstanding | 4.47 | 4.41 | 4.34 | 4.22 | 4.12 | Upgrade
|
| Total Common Shares Outstanding | 4.47 | 4.41 | 4.34 | 4.21 | 4.11 | Upgrade
|
| Working Capital | 26.27 | -9.84 | 22.5 | 27.88 | 36.27 | Upgrade
|
| Book Value Per Share | 3.07 | 14.37 | 16.84 | 17.16 | 20.27 | Upgrade
|
| Tangible Book Value | -3.46 | -4.12 | -0.03 | -5.05 | -1.67 | Upgrade
|
| Tangible Book Value Per Share | -0.77 | -0.93 | -0.01 | -1.20 | -0.41 | Upgrade
|
| Machinery | 20.24 | 18.36 | 15.95 | 15.71 | 15.3 | Upgrade
|
| Leasehold Improvements | 2.67 | 2.57 | 2.42 | 2.51 | 2.56 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.